Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Apr 12, 2013

NEW YORK (GenomeWeb News) – Molecular diagnostics and cytology test developer Veracyte said this week that it has named Shelly Guyer to be its chief financial officer.

Guyer formerly was CFO and executive VP of finance and administration at iRhythm Technologies, and she was VP of business development and investor relations at the biotech firm Nuvelo. She also spent 17 years at JP Morgan Securities and its predecessor companies, where she led financing for large- and small-cap life sciences firms.

The South San Francisco-based firm has developed and is now offering its first product, the Afirma Thyroid FNA Analysis test for improving thyroid nodule diagnosis, through a global partnership with Genzyme.


Benitec Biopharma has appointed Kevin Buchi to its board of directors.

Buchi previously served as CEO of Cephalon prior to its acquisition by Teva Pharmaceutical in 2011.

He currently sits on the boards of Stemline Therapeutics, Forward Pharma, and Alexza Pharamceuticals.


Karolinska Development has nominated Bo Jesper Hansen to be chairman of its board.

The for-profit company seeks to move medical innovations toward commercialization, particularly through agreements with Karolinska Institute Innovations and Nordic universities. If approved, Hansen will succeed Hans Wigzell in the position in October. Wigzell will remain on the board as an ordinary member after Hansen assumes the chair.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.